Roberta Bruhn1,2, Matthew S Karafin3, Joan F Hilton2, Zhanna Kaidarova1, Bryan R Spencer4, Lirong Qu5, Edward L Snyder6, Rebecca Olin2, Edward L Murphy1,2, Elizabeth St Lezin7,8. 1. Vitalant Research Institute, San Francisco, CA, USA. 2. University of California San Francisco, San Francisco, CA, USA. 3. Versiti, Milwaukee, WI, USA. 4. American Red Cross, Scientific Affairs, Dedham, MA, USA. 5. Institute for Transfusion Medicine, Pittsburgh, PA, USA. 6. Yale Medical School, New Haven, CT, USA. 7. University of California San Francisco, San Francisco, CA, USA. Elizabeth.st.lezin@va.gov. 8. San Francisco Veterans Affairs Health Care System, Department of Laboratory Medicine 113A, 4150 Clement Street, San Francisco, CA, 94121, USA. Elizabeth.st.lezin@va.gov.
Abstract
PURPOSE: Outpatients with hematologic disease often receive red cell transfusion to treat anemia and fatigue. The effect of transfusion on fatigue-related quality of life and how well this effect is sustained has not been quantified. The study aim was to describe the early and sustained impact over 4 weeks of red cells on patient-reported fatigue in outpatients age ≥ 50 receiving transfusion as routine clinical care. METHODS: FACIT-Fatigue scale scores were measured pre-transfusion and at visits targeting 3, 7, and 28 days post-transfusion. Group-based trajectory modeling of patient fatigue scores by study day was used to identify the number of distinct trajectories (Groups), then longitudinal mixed effects modeling of fatigue scores was used to estimate group-specific mean improvements early after transfusion and between days 3 and 28 post-transfusion. RESULTS: Four distinct fatigue score trajectory groups were identified and were found to be correlated with baseline fatigue scores (means 12, 26, 34, and 47 points). In the three groups with the lowest fatigue trajectories (indicating greater fatigue), improvements in fatigue early after transfusion achieved the established minimum clinically important difference (≥ 3 points, Group p = 0.0039). In all trajectory groups, mean fatigue levels did not change significantly between 3 and 28 days (± 1 point, Group p = 0.60). CONCLUSION: Patient-reported fatigue varies widely among older adult outpatients with hematologic disorders. Nonetheless, trajectory modeling suggests that most anemic patients can expect a noticeable improvement in fatigue in the first few days after transfusion that generally is sustained up to 4 weeks.
PURPOSE: Outpatients with hematologic disease often receive red cell transfusion to treat anemia and fatigue. The effect of transfusion on fatigue-related quality of life and how well this effect is sustained has not been quantified. The study aim was to describe the early and sustained impact over 4 weeks of red cells on patient-reported fatigue in outpatients age ≥ 50 receiving transfusion as routine clinical care. METHODS:FACIT-Fatigue scale scores were measured pre-transfusion and at visits targeting 3, 7, and 28 days post-transfusion. Group-based trajectory modeling of patientfatigue scores by study day was used to identify the number of distinct trajectories (Groups), then longitudinal mixed effects modeling of fatigue scores was used to estimate group-specific mean improvements early after transfusion and between days 3 and 28 post-transfusion. RESULTS: Four distinct fatigue score trajectory groups were identified and were found to be correlated with baseline fatigue scores (means 12, 26, 34, and 47 points). In the three groups with the lowest fatigue trajectories (indicating greater fatigue), improvements in fatigue early after transfusion achieved the established minimum clinically important difference (≥ 3 points, Group p = 0.0039). In all trajectory groups, mean fatigue levels did not change significantly between 3 and 28 days (± 1 point, Group p = 0.60). CONCLUSION:Patient-reported fatigue varies widely among older adult outpatients with hematologic disorders. Nonetheless, trajectory modeling suggests that most anemicpatients can expect a noticeable improvement in fatigue in the first few days after transfusion that generally is sustained up to 4 weeks.
Entities:
Keywords:
Fatigue; Fatigue-related quality of life; Patient-reported outcomes; Red blood cells; Transfusion practice
Authors: Jeffrey L Carson; Brenda J Grossman; Steven Kleinman; Alan T Tinmouth; Marisa B Marques; Mark K Fung; John B Holcomb; Orieji Illoh; Lewis J Kaplan; Louis M Katz; Sunil V Rao; John D Roback; Aryeh Shander; Aaron A R Tobian; Robert Weinstein; Lisa Grace Swinton McLaughlin; Benjamin Djulbegovic Journal: Ann Intern Med Date: 2012-07-03 Impact factor: 25.391
Authors: Simon J Stanworth; Sally Killick; Zoe K McQuilten; Marina Karakantza; Robert Weinkove; Heather Smethurst; Laura A Pankhurst; Renate L Hodge; Valerie Hopkins; Helen L Thomas; Alison J Deary; Jeannie Callum; Yulia Lin; Erica M Wood; Rena Buckstein; David Bowen Journal: Br J Haematol Date: 2020-01-20 Impact factor: 6.998
Authors: Tamara E Lacourt; Annemieke Kavelaars; Maro Ohanian; Nina D Shah; Samuel A Shelburne; Andrew Futreal; Dimitrios P Kontoyiannis; Cobi J Heijnen Journal: Oncotarget Date: 2018-07-27